Nuzenio

Nail Psoriasis

Nail Psoriasis entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 2 latest news signals 2 publisher sources 100/100 entity strength

Latest news

Palmoplantar Psoriasis Data Show Zasocitinib Edge Over Apremilast - Dermatology TimesDermatology Times · Thu, 06 Aug 2026 21:20:59 GMT Onychoscopy in Nail Psoriasis: A Narrative Review of Diagnostic Utility, Disease Severity Assessment, Musculoskeletal Associations, and Treatment Monitoring - CureusCureus · Tue, 04 Aug 2026 06:06:23 GMT

Timeline

Thu, 06 Aug 2026 21:20:59 GMTPalmoplantar Psoriasis Data Show Zasocitinib Edge Over Apremilast - Dermatology Times

Tue, 04 Aug 2026 06:06:23 GMTOnychoscopy in Nail Psoriasis: A Narrative Review of Diagnostic Utility, Disease Severity Assessment, Musculoskeletal Associations, and Treatment Monitoring - Cureus

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

A Narrative Review2 live mentions Diagnostic Utility2 live mentions Disease Severity Assessment2 live mentions Musculoskeletal Associations2 live mentions Palmoplantar Psoriasis Data1 live mentions Show Zasocitinib Edge1 live mentions Over Apremilast1 live mentions Dermatology Times Palmoplantar1 live mentions Psoriasis Data Show1 live mentions Zasocitinib Edge Over1 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Nail Psoriasis.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.